IE 11 is not supported. For an optimal experience visit our site on another browser.
Ozempic-maker Novo Nordisk struggles as GLP-1 drugs continue to dominate medicine, culture 
March 11, 202603:42
  • UP NEXT

    NBC News investigates patient deaths following cosmetic surgery

    03:52

  • Highly contagious measles virus costing the U.S. millions

    02:32

  • Lawsuit alleges insurance company provider list is a “Ghost Network”

    03:31

  • National Institutes of Health facing widespread vacancies in director roles

    02:55

  • Why Affordable Care Act sign-ups are falling nationwide

    03:06

  • Deaths from flu surge across the country

    01:49

  • House passes three year Affordable Care Act tax credits extension

    03:21

  • Millions of Americans in limbo over Affordable Care Act subsidies

    02:02

  • Explosive growth of doctors choosing direct primary care

    03:03

  • Many Obamacare premiums expected to spike after votes on health care plans fail

    02:15

  • Surrogacy company suddenly shuts down, leaving families and surrogates in limbo

    02:35

  • Family uses external review to overturn insurance denial

    03:49

  • Lawmakers spar over future of health insurance costs as subsidies are set to expire

    04:59

  • CDC panel votes to recommend delaying hepatitis B vaccine for babies

    01:52

  • Texas hospital fires staffer after viral video showing pregnant woman in distress

    01:19

  • Mother fights to get coverage for daughter’s scoliosis surgery

    03:34

  • Behind the scenes of Prenuvo, the health startup providing full-body MRI scans

    04:51

  • Mounting concerns over Black women’s maternal healthcare treatment

    02:05

  • Step therapy requires patients try alternate medication

    03:04

  • Long-term care insurance policy premiums skyrocket

    03:34

Hallie Jackson NOW

Ozempic-maker Novo Nordisk struggles as GLP-1 drugs continue to dominate medicine, culture 

Catch up with NBC News Clone on today's hot topic: Ozempic Maker Novo Nordisk Struggles As Glp 1 Drugs Continue To Dominate Medicine Culture 259157573669 - Breaking News | NBC News Clone. Our editorial team reformatted this story for clarity and speed.

03:42

The FDA criticized the maker of Ozempic and Wegovy, Novo Nordisk, for “serious violations” related to the reporting of possible side effects linked to semaglutide, the active ingredient in the drug. NBC News’ Emily Lorsch reports on the GLP-1 drugs. March 11, 2026

Get more newsOzempic Maker Novo Nordisk Struggles As Glp 1 Drugs Continue To Dominate Medicine Culture 259157573669 - Breaking News | NBC News Cloneon
  • UP NEXT

    NBC News investigates patient deaths following cosmetic surgery

    03:52

  • Highly contagious measles virus costing the U.S. millions

    02:32

  • Lawsuit alleges insurance company provider list is a “Ghost Network”

    03:31

  • National Institutes of Health facing widespread vacancies in director roles

    02:55

  • Why Affordable Care Act sign-ups are falling nationwide

    03:06

  • Deaths from flu surge across the country

    01:49
Get more newsLiveon

Best of NBC News

Play All
Play All
×
AdBlock Detected!
Please disable it to support our content.

Related Articles

Donald Trump Presidency Updates - Politics and Government | NBC News Clone | Inflation Rates 2025 Analysis - Business and Economy | NBC News Clone | Latest Vaccine Developments - Health and Medicine | NBC News Clone | Ukraine Russia Conflict Updates - World News | NBC News Clone | Openai Chatgpt News - Technology and Innovation | NBC News Clone | 2024 Paris Games Highlights - Sports and Recreation | NBC News Clone | Extreme Weather Events - Weather and Climate | NBC News Clone | Hollywood Updates - Entertainment and Celebrity | NBC News Clone | Government Transparency - Investigations and Analysis | NBC News Clone | Community Stories - Local News and Communities | NBC News Clone